Selinexor for Heavily Pretreated RRRMM

Video

test 3

Newsletter

Stay up to date on recent advances in the multidisciplinary approach to cancer.

Subscribe Now!
Recent Videos
The requirement for morphological dysplasia may become less important in the presence of molecular drivers of myelodysplastic syndrome.
Related Content
ABBV-706 Demonstrates Tumor Shrinkage, Tolerability in Pretreated R/R SCLC

ABBV-706 Demonstrates Tumor Shrinkage, Tolerability in Pretreated R/R SCLC

Ashling Wahner
September 10th 2025
Article
Upfront risk stratification for additional cardiovascular testing may help mitigate cardiovascular toxicities in breast cancer treatment.

Cardiovascular Considerations in Breast Cancer Treatment and Survivorship

Joseph S. Wallins, MD, MPH
September 10th 2025
Podcast
Crizotinib Falls Short on DFS and OS Improvements in ALK+ NSCLC

Crizotinib Falls Short on DFS and OS Improvements in ALK+ NSCLC

Jax DiEugenio
September 10th 2025
Article
Man Up? The Truth About Men's Health After Cancer

Man Up? The Truth About Men's Health After Cancer

Daniel C. McFarland, DO;Christian J. Nelson, PhD
September 10th 2025
Podcast
ProSense® is a minimally invasive treatment option that destroys tumors by freezing them, utilizing liquid nitrogen to create large lethal zones for maximum efficacy in tumor destruction.

ProSense® Cryoablation Satisfies Patients With Breast Cancer vs Alternatives

Tim Cortese
September 10th 2025
Article
Frontline Aumolertinib/Chemo Yields PFS Superiority in EGFR+ NSCLC

Frontline Aumolertinib/Chemo Yields PFS Superiority in EGFR+ NSCLC

Jax DiEugenio
September 10th 2025
Article